300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Yingke Capital, VC Fund

Yingke Capital

VC Fund

Fuzhou, China

Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&D and productioncapacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.

Total investments:
104
Last investment:
Lead investor:
43%

Last updated:

Industries Yingke Capital invests in

Health CareBiotechnologyManufacturingMedicalPharmaceutical

Stages Yingke Capital invests in

Series CVenture - Series UnknownSeries BSeries ASeed

Countries Yingke Capital invests in

ChinaUnited StatesTaiwan

Round sizes

Series B $14M–$412MSeries C $86k–$130MVenture - Series Unknown $1M–$672M

Contacts

NameEmailPhoneSocials
See all 7 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series B
$14M–$412M
Series C
$86k–$130M
Venture - Series Unknown
$1M–$672M

Investment Focus

Industry

  • Health Care 26 (25%)
  • Biotechnology 24 (23%)
  • Manufacturing 23 (22%)
  • Medical 19 (18%)
  • Pharmaceutical 15 (14%)
See all 93 industries →

Stage

  • Series C 15 (14%)
  • Venture - Series Unknown 15 (14%)
  • Series B 14 (13%)
  • Series A 13 (13%)
  • Seed 11 (11%)
See all 12 stages →

Country

  • China 81 (78%)
  • United States 5 (5%)
  • Taiwan 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Chen Yulei Chief Investment Officer
Chief Investment Officer Total investments: 1 Find email
Manying Lai
Manying Lai President
President Total investments: 0
Find email
Shi Zhengzheng Partner
Partner Total investments: 2 Find email
Shuqing Wu
Shuqing Wu President of Financial Division
President of Financial Division Total investments: 0
Find email
Xiaochen Zhou
Xiaochen Zhou Vice-President
Vice-President Total investments: 0
Find email
See all 7 team members →

Investments

CompanyDescriptionRoundLinks
Sibo Medical
Sibo Medical is dedicated to the study and creation of fully automated interventional surgical robots that are magnetically controlled. $14.9M / Seed / Sep 17, 2026
Physen AI
Physen AI is a specialized physical interaction data infrastructure company focused on the embodied intelligence and robotics sector. Angel / Jul 29, 2026
Listenai is an enterprise that provides AI chips and industry solutions for the field of artificial intelligence and the Internet of Things. $73.7M / Series B / Jul 10, 2026
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. $73.6M / Seed / May 11, 2026
Yizhu Technology is a software company that specializes in AI computing power, engineering and consulting for storage data. Venture - Series Unknown / Oct 29, 2025
Lingdong General
Lingdong General is a manufacturing company that provides research and development for industrial and service consumer robots. Angel / Aug 12, 2025
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. Angel / Aug 07, 2025
Junde Pharmaceutical Junde Pharmaceutical
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for thefull cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease. $13.7M / Series A / Apr 18, 2025
WestGene Biopharma is a high-tech enterprise that focuses on the research and development, manufacturing and sales of mRNA therapeutics and adjuvants. $41.8M / Series A / Jun 20, 2023
EnCureGen Pharmaceuticals EnCureGen Pharmaceuticals
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases. Seed / Jun 08, 2023
See all 104 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Facebook
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Mali
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yingke Capital invest in?

Yingke Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series C and Venture - Series Unknown stage. Most of the 104 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Yingke Capital's check size?

Yingke Capital typically joins rounds of $14M–$412M at Series B, $86k–$130M at Series C and $1M–$672M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yingke Capital participates in.

How do I contact Yingke Capital?

Public channels for Yingke Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Yingke Capital?

The team at Yingke Capital includes Chen Yulei (Chief Investment Officer), Manying Lai (President) and Shi Zhengzheng (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yingke Capital Yingke Capital Find emails